Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study.
about
Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling.Computational toxicology of chloroform: reverse dosimetry using Bayesian inference, Markov chain Monte Carlo simulation, and human biomonitoring data.Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.Reconstruction of Exposure to m-Xylene from Human Biomonitoring Data Using PBPK Modelling, Bayesian Inference, and Markov Chain Monte Carlo Simulation.Analysis of biomarker utility using a PBPK/PD model for carbaryl.A Bayesian population PBPK model for multiroute chloroform exposure.Reconstructing population exposures to environmental chemicals from biomarkers: challenges and opportunities.Application of physiologically based pharmacokinetic models in chemical risk assessment.A probabilistic model of human variability in physiology for future application to dose reconstruction and QIVIVE.Population physiologically based pharmacokinetic modeling for the human lactational transfer of PCB-153 with consideration of worldwide human biomonitoring results.PROcEED: Probabilistic reverse dosimetry approaches for estimating exposure distributions.Influence of systems biology response and environmental exposure level on between-subject variability in breath and blood biomarkers.The role of exposure reconstruction in occupational human health risk assessment: current methods and a recommended framework.Reconstructing human exposures using biomarkers and other "clues".Exposure information in environmental health research: current opportunities and future directions for particulate matter, ozone, and toxic air pollutants.Public health interpretation of trihalomethane blood levels in the United States: NHANES 1999-2004.Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).Reconstructing exposures from small samples using physiologically based pharmacokinetic models and multiple biomarkers.
P2860
Q31077784-A5BF14B6-2842-4C9B-980C-A58D1BBB526DQ31172049-2156029A-5E80-4336-8DBE-53D63ED49BE9Q34181630-80FCCBDC-6C03-4856-9861-542F228491A8Q34311634-9E690652-5D90-4377-8A55-12614296BB29Q34530976-0C2850BA-1099-42C6-84AC-A88AC349878AQ34714840-88922A9F-83C5-40B6-9961-B2CC3C57E28AQ34746222-498D4A49-4C93-4EAE-B2DE-ED729FE9B748Q35864986-FA140558-2991-4DA2-B9E4-A7B72430CA60Q36146247-766DC67D-18D3-4AFC-ADC0-6E6B8AB53B79Q37007960-6DD00FB8-0249-465C-95E8-71A351AAC3A8Q37067088-A48EA5A4-67F8-4047-9B3F-F994D8FD689FQ37594115-61EFBCEF-C3A3-46D7-8B0D-213ED6DD0F9AQ37781049-59C1DCE6-5DEC-426B-9590-4627442AC735Q37971821-78A2B37C-F04E-4F9F-9AA8-44052A638BB7Q40107026-DF7798F4-0EF6-45CD-91F2-CF50DE9FDE37Q45955962-1C39D752-1A5C-4383-B69C-D7534FA7EFD4Q46245060-87AC354D-D225-420A-A57C-169CD5E7895DQ46609020-93BD620F-1343-45A3-A72A-F7F3E59D38EE
P2860
Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Reconstructing population expo ...... thylene (TCE) as a case study.
@en
type
label
Reconstructing population expo ...... thylene (TCE) as a case study.
@en
prefLabel
Reconstructing population expo ...... thylene (TCE) as a case study.
@en
P2860
P356
P1476
Reconstructing population expo ...... ethylene (TCE) as a case study
@en
P2093
Michael D Sohn
Thomas E McKone
P2860
P2888
P304
P356
10.1038/SJ.JEA.7500314
P577
2004-05-01T00:00:00Z